These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 6787220

  • 1. Aldose reductase in diabetic cataracts.
    Kinoshita JH, Kador P, Catiles M.
    JAMA; 1981 Jul 17; 246(3):257-61. PubMed ID: 6787220
    [No Abstract] [Full Text] [Related]

  • 2. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF, Akagi Y, Kinoshita JH.
    Metabolism; 1986 Apr 17; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [Abstract] [Full Text] [Related]

  • 3. Introduction: evidence for the role of the polyol pathway in the pathophysiology of diabetic complications.
    Beyer TA, Hutson NJ.
    Metabolism; 1986 Apr 17; 35(4 Suppl 1):1-3. PubMed ID: 3083197
    [No Abstract] [Full Text] [Related]

  • 4. Nonosmotic diabetic cataracts.
    Malone JI, Lowitt S, Cook WR.
    Pediatr Res; 1990 Mar 17; 27(3):293-6. PubMed ID: 2138728
    [Abstract] [Full Text] [Related]

  • 5. Lens aldose reductase in diabetic and galactosemic cataracts.
    Parmar NS, Ghosh MN.
    Indian J Physiol Pharmacol; 1981 Mar 17; 25(3):193-200. PubMed ID: 6795119
    [No Abstract] [Full Text] [Related]

  • 6. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H, Nozawa Y, Hayano S.
    Nippon Ganka Gakkai Zasshi; 1982 Mar 17; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract] [Full Text] [Related]

  • 7. Studies on cataractogenesis in humans and in rats with alloxan-induced diabetes. II. Histochemical evaluation of lenticular enzymes.
    Ahmad SS, Tsou KC, Ahmad SI, Rahman MA.
    Ophthalmic Res; 1985 Mar 17; 17(1):12-20. PubMed ID: 2984623
    [Abstract] [Full Text] [Related]

  • 8. Lens metabolism and cellular effects of aldose reductase.
    McLean P, Gonzalez AM, Sochor M, Hothersall JS.
    Diabet Med; 1985 May 17; 2(3):189-93. PubMed ID: 2952418
    [No Abstract] [Full Text] [Related]

  • 9. NIH conference. Aldose reductase and complications of diabetes.
    Cogan DG, Kinoshita JH, Kador PF, Robison G, Datilis MB, Cobo LM, Kupfer C.
    Ann Intern Med; 1984 Jul 17; 101(1):82-91. PubMed ID: 6203454
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical localization for aldose reductase in diabetic lenses.
    Akagi Y, Kador PF, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1987 Jan 17; 28(1):163-7. PubMed ID: 3100473
    [Abstract] [Full Text] [Related]

  • 11. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM, González RG.
    Metabolism; 1986 Apr 17; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [Abstract] [Full Text] [Related]

  • 12. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF, Lee JW, Fujisawa S, Blessing K, Lou MF.
    J Ocul Pharmacol Ther; 2000 Apr 17; 16(2):149-60. PubMed ID: 10803425
    [Abstract] [Full Text] [Related]

  • 13. [Clinical application of aldose reductase inhibitors--prevention and therapy of diabetic complications].
    Hotta N, Sakamoto N.
    Nihon Rinsho; 1987 Dec 17; 45(12):3010-27. PubMed ID: 3128677
    [No Abstract] [Full Text] [Related]

  • 14. Formation of sorbitol 6-phosphate by bovine and human lens aldose reductase, sorbitol dehydrogenase and sorbitol kinase.
    Srivastava SK, Ansari NH, Brown JH, Petrash JM.
    Biochim Biophys Acta; 1982 Aug 06; 717(2):210-4. PubMed ID: 6288113
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. NADPH-dependent reduction of glyceraldehyde: a unusually high activity in the lens of the camel (Camelus dromedarius).
    Del Corso A, Osman AM, Mohamed AS, Camici M, Barsacchi D, Tozzi MG, Mura U.
    Boll Soc Ital Biol Sper; 1989 Mar 06; 65(3):235-42. PubMed ID: 2504255
    [Abstract] [Full Text] [Related]

  • 18. Differences in the susceptibility of various aldose reductases to inhibition. II.
    Kador PF, Kinoshita JH, Tung WH, Chylack LT.
    Invest Ophthalmol Vis Sci; 1980 Aug 06; 19(8):980-2. PubMed ID: 6773903
    [Abstract] [Full Text] [Related]

  • 19. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF, Akagi Y, Kinoshita JH.
    Diabet Med; 1985 May 06; 2(3):194-6. PubMed ID: 2952419
    [No Abstract] [Full Text] [Related]

  • 20. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H, Akagi Y, Yoshikawa T, Ikebe H, Takahashi Y, Chamoto K, Miyamoto Y, Terubayashi H.
    Nippon Ganka Gakkai Zasshi; 1987 Feb 06; 91(2):246-53. PubMed ID: 3111200
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.